Trevena (NASDAQ:TRVN) Stock Price Passes Above Fifty Day Moving Average – Time to Sell?

Trevena, Inc. (NASDAQ:TRVN) passed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $0.00 and traded as high as $0.0003. Trevena shares last traded at $0.0003, with a volume of 346 shares trading hands.

Trevena Stock Performance

Trevena Company Profile

Trevena, Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of biased ligand G protein-coupled receptor (GPCR) selective medicines. By leveraging its proprietary bias-ligand technology platform, Trevena aims to create therapies that preferentially activate beneficial signaling pathways while minimizing engagement of pathways linked to adverse effects. The company’s research efforts target areas of high unmet medical need, including pain management, cardiometabolic disorders and central nervous system conditions.

The company’s lead compound, oliceridine (also known by its brand name OLINVEO), is a G protein-biased μ-opioid receptor agonist designed for the treatment of moderate to severe acute pain in the hospital setting.